New drug duo aims to slow advanced liver cancer
Disease control
Recruiting now
This study tests whether adding chemotherapy to a two-drug combination (camrelizumab and apatinib) helps people with advanced liver cancer live longer without their disease getting worse. About 326 adults with liver cancer that cannot be removed by surgery will be randomly assign…
Phase: PHASE3 • Sponsor: Linhui Peng • Aim: Disease control
Last updated Jun 11, 2026 12:10 UTC